Jing Zhang

Title: The Innovative Contributions of Jing Zhang

Introduction

Jing Zhang is a notable inventor based in Sudbury, MA (US), recognized for his significant contributions to the field of antibacterial compounds and methods. With a total of two patents to his name, Zhang's work focuses on addressing bacterial infections, particularly those caused by drug-resistant organisms.

Latest Patents

Zhang's latest patents include "Compounds and methods for treating bacterial infections," which presents antibacterial compounds represented by Formula I, or a pharmaceutically acceptable salt thereof. This patent also details pharmaceutical compositions that incorporate these compounds. Another significant patent is for "Beta-lactamase inhibitor compounds," which describes compounds that act as beta-lactamase inhibitors. These compounds, along with their pharmaceutically acceptable salts, are designed to be used in combination with beta-lactam antibiotics for treating bacterial infections, including those caused by multi-drug resistant organisms.

Career Highlights

Jing Zhang is currently employed at Entasis Therapeutics, Inc., where he continues to innovate in the field of pharmaceuticals. His work is pivotal in developing new treatments that combat bacterial infections effectively.

Collaborations

Zhang collaborates with talented individuals such as Janelle Comita-Prevoir and Thomas Francois Durand-Reville, contributing to a dynamic research environment that fosters innovation.

Conclusion

Jing Zhang's contributions to antibacterial research and his innovative patents highlight his commitment to improving healthcare solutions. His work is essential in the ongoing battle against drug-resistant bacterial infections.